Trials / Completed
CompletedNCT02411994
Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria
Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Uncomplicated Falciparum Malaria in Western Kenya
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 197 (actual)
- Sponsor
- Royal Tropical Institute · Academic / Other
- Sex
- All
- Age
- 6 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy of pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pyronaridine-artesunate | |
| DRUG | Artemether-lumefantrine combination |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2015-04-08
- Last updated
- 2017-11-27
Locations
1 site across 1 country: Kenya
Source: ClinicalTrials.gov record NCT02411994. Inclusion in this directory is not an endorsement.